Chennai: Following a good second quarter, Lanxess has again raised its guidance for the full year 2021.
The specialty chemicals company now expects EBITDA pre exceptionals to be between EUR 1 billion and EUR 1.05 billion.
The guidance also reflects the acquisition of Emerald Kalama Chemical, which was completed in early August, with an EBITDA contribution of around EUR 35 million for the remainder of 2021. Previously, Lanxess expected earnings of between EUR 950 million and EUR 1 billion.